论文部分内容阅读
本文报告我所应用一种新的放射性药物~(99m) Tc-HM-PAO进行SPECT脑血流显像14例的结果。其中脑血管病10例;癫痫3例;偏头痛1例。所得影像除1例脑血管畸形表现为脑局部血流量增加外,其余均显示局部血流量减低。我们将所得结果与XCT、DSA及MRI的影像进行了对比,表明: ~(99m) Tc-HM-PAO是一种良好的脑血流显像剂,应用该剂进行SPECT脑血流显像对脑血管病的诊断,外科治疗效果的评价及癫痫病灶的定位等有一定优越性,对观察病人的脑血液供应及脑功能的异常有重要价值。
This article reports the results of 14 cases of SPECT cerebral blood flow imaging using a new radiopharmaceutical 99m Tc-HM-PAO. Including cerebrovascular disease in 10 cases; 3 cases of epilepsy; migraine in 1 case. In addition to 1 cases of cerebrovascular malformations showed increased local blood flow, the rest showed that local blood flow decreased. We compared the results obtained with XCT, DSA and MRI images, indicating that: 99m Tc-HM-PAO is a good cerebral blood flow imaging agent, the application of this agent for SPECT cerebral blood flow imaging The diagnosis of cerebrovascular disease, the evaluation of the effect of surgical treatment and the location of epileptic foci have some advantages. They are of great value in observing the patient’s cerebral blood supply and abnormal brain function.